The Multi-Ethnic Study of Atherosclerosis (MESA) is a longitudinal cohort study of African, Chinese and Hispanic Americans, as well as non-Hispanic Whites. Details about the study design have been ...

A potential association between the use of angiotensin-receptor blockers (ARBs) and angiotensin-converting–enzyme (ACE) inhibitors and the risk of coronavirus disease 2019 (Covid-19) has not been well ...

An aldosterone antagonist (AA) should be the drug of choice when adding a second renin-angiotensin-aldosterone system (RAAS) blocker to ACE inhibitors in patients with symptomatic systolic HF despite ...

ACE inhibitors and angiotensin-receptor blockers have been found to effectively slow progression of kidney disease. It has been theorized that dual blockade of the renin-angiotensin-aldosterone system ...

Objectives: This study examined renin-angiotensin-aldosterone system (RAAS) inhibitor dose levels in a US patient population and investigated the impact of hyperkalemia on RAAS inhibitor dose and the ...

Background Altitude training produces advantages over sea level training, but athletes require acclimatization to avoid discomfort or mountain sickness, in which the blood pressure control is ...

Please provide your email address to receive an email when new articles are posted on . WASHINGTON — Patiromer was effective in controlling serum potassium in hyperkalemic patients with diabetes and ...

Low blood pressure is frequent in the akinetic form of Parkinson's disease. A low renin activity in plasma as well as a low rate of aldosterone secretion is demonstrated in these patients. Renin ...

Evaluated renin-angiotensin-aldosterone system (RAAS) inhibitor drugs and their maximum doses, listed in descending order of observed frequency at index: lisinopril, 40 mg; losartan, 100 mg; valsartan ...

The aldosterone-renin screening market is forecasted to grow from USD 574.8 million in 2025 to USD 1,109.7 million by 2035, at a CAGR of 6.8% during the forecast period. The aldosterone-renin ...

There is concern about the potential of an increased risk related to medications that act on the renin–angiotensin–aldosterone system in patients exposed to coronavirus disease 2019 (Covid-19), ...